| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/19/2002 | WO2002072827A1 Traf3-binding b cell-specific receptor |
| 09/19/2002 | WO2002072794A2 Immunoglobulin superfamily proteins |
| 09/19/2002 | WO2002072778A2 Method for identifying inhibitors of g protein coupled receptor signaling |
| 09/19/2002 | WO2002072769A2 Human serpin polypeptides |
| 09/19/2002 | WO2002072636A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 09/19/2002 | WO2002072631A2 Mhc molecule constructs and their usesfor diagnosis and therapy |
| 09/19/2002 | WO2002072630A2 Nucleic acid-associated proteins |
| 09/19/2002 | WO2002072620A1 Tumour targeting prodrugs activated by metallo matrixproteinases |
| 09/19/2002 | WO2002072618A1 Novel peptide ligands of leukocyte integrins |
| 09/19/2002 | WO2002072608A2 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS |
| 09/19/2002 | WO2002072607A2 Soluble heterodimeric cytokine receptor |
| 09/19/2002 | WO2002072585A2 Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 09/19/2002 | WO2002072584A2 Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders |
| 09/19/2002 | WO2002072579A1 Triazolopyridines as anti-inflammatory agents |
| 09/19/2002 | WO2002072577A2 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors. |
| 09/19/2002 | WO2002072573A1 Imidazolidine derivatives, their preparation, and their use as antinflamatory agent. |
| 09/19/2002 | WO2002072571A2 Pyridinyl pyrazoles useful for the treatment of copd |
| 09/19/2002 | WO2002072564A1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same |
| 09/19/2002 | WO2002072562A1 Medicinal composition containing 1,3-thiazine derivative |
| 09/19/2002 | WO2002072559A1 Process to intermediates for biologically active compounds |
| 09/19/2002 | WO2002072558A1 Anti-thrombotic carboxylic acid amides, the production thereof and use of the same as medicaments |
| 09/19/2002 | WO2002072550A1 Substituted dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-yl methyl]-amines and the use of the same as analgesics |
| 09/19/2002 | WO2002072548A2 Heterocyclic compounds and their use as histamine h4 ligands. |
| 09/19/2002 | WO2002072543A2 Rxr activating molecules |
| 09/19/2002 | WO2002072542A2 Ph-dependent nmda receptor antagonists |
| 09/19/2002 | WO2002072536A1 Urea derivatives having vanilloid receptor (vr1) antagonist activity |
| 09/19/2002 | WO2002072534A2 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof |
| 09/19/2002 | WO2002072528A1 Fluorinated trienes and their use as rxr modulators |
| 09/19/2002 | WO2002072527A2 1-butyric acid derivatives such as carbomethoxypropionyl cyanide or leflunomide derivatives, and the therapeutic use thereof |
| 09/19/2002 | WO2002072202A1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 09/19/2002 | WO2002072134A1 Remedies for arthritis deformans and remedies for rheumatoid arthritis |
| 09/19/2002 | WO2002072120A1 Compositions comprising matrine and dictamnine for treating or preventing cancer and other diseases |
| 09/19/2002 | WO2002072112A1 Use of selenite or preparations containing selenite for treating wounds |
| 09/19/2002 | WO2002072103A1 Use of type 4 phosphodiesterase inhibitors in myocardial diseases |
| 09/19/2002 | WO2002072095A2 Tiotropium salts for treating inflammatory diseases |
| 09/19/2002 | WO2002072083A1 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 09/19/2002 | WO2002072035A2 Novel anti-inflammatory compositions and methods of use |
| 09/19/2002 | WO2002072031A2 Substituted tetracycline compounds as synergistic antifungal agents |
| 09/19/2002 | WO2002072030A2 High affinity integrin polypeptides and uses thereof |
| 09/19/2002 | WO2002072019A2 Interferon-beta polynucleotide therapy for autoimmune and inflammatory diseases |
| 09/19/2002 | WO2002072011A2 Stabilized therapeutic and imaging agents |
| 09/19/2002 | WO2002072003A2 Use of steroid derivatives for the treatment of a benighn and/or malignant tumour |
| 09/19/2002 | WO2002071874A2 Composition improving age-related physiological deficits and increasing longevity |
| 09/19/2002 | WO2002071827A2 Retinoid x receptor modulators |
| 09/19/2002 | WO2002058680A3 Use of bicylic amino acids for preventing and treating visceral pain and gastrointestinal disorders |
| 09/19/2002 | WO2002055532A3 Variant growth hormone molecules conjugated with macromolecular compounds |
| 09/19/2002 | WO2002053534A8 Vla-4 inhibitors |
| 09/19/2002 | WO2002050028A3 Substituted benzoindoles as spla2 inhibitors |
| 09/19/2002 | WO2002036106A3 Novel medicament compositions based on anticholinergics and corticosteroids |
| 09/19/2002 | WO2002030409A8 Methods for the treatment of a traumatic central nervous system injury |
| 09/19/2002 | WO2002024194A9 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
| 09/19/2002 | WO2002018553A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/19/2002 | WO2002018341A3 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors |
| 09/19/2002 | WO2002014355A3 Novel mitogen activated kinase |
| 09/19/2002 | WO2002014311A3 Urea compounds and methods of uses |
| 09/19/2002 | WO2002010192A3 Somatostatin analogues |
| 09/19/2002 | WO2002002610A3 Secretion and trafficking molecules |
| 09/19/2002 | WO2001072702A3 Amidino compounds useful as nitric oxide synthase inhibitors |
| 09/19/2002 | WO2001035899A9 Inhibitors of helicobacter pylori induced gastrointestinal diseases |
| 09/19/2002 | US20020133005 Heterocyclic compounds and medical use thereof |
| 09/19/2002 | US20020132853 Diaryl piperazines and related compounds useful in the treatment of a chronic and acute pain conditions, itch and urinary incontinence. |
| 09/19/2002 | US20020132852 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use |
| 09/19/2002 | US20020132849 2-Amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 09/19/2002 | US20020132847 Inhibition of TNF-alpha-initiated neutrophil response |
| 09/19/2002 | US20020132833 Caspase inhibitors and uses thereof |
| 09/19/2002 | US20020132830 Use of beta 2 bronchodilator drugs |
| 09/19/2002 | US20020132825 Analgesic combination of oxycodone and celecoxib |
| 09/19/2002 | US20020132823 Assay method |
| 09/19/2002 | US20020132822 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 09/19/2002 | US20020132810 Novel heterocyclic amide derivatives |
| 09/19/2002 | US20020132809 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production |
| 09/19/2002 | US20020132807 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 09/19/2002 | US20020132796 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid. |
| 09/19/2002 | US20020132330 Polypeptide for use in the treatment, prevention and diagnosis of inflammation, cell proliferation and apoptosis |
| 09/19/2002 | US20020132324 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/19/2002 | US20020132297 Nucleotide sequences coding protein for use in the treatment nflammatory bowel disease, sepsis, viral diseases and rheumatoid arthritis |
| 09/19/2002 | US20020132296 Human Ste20-like stress activated serine/threonine kinase |
| 09/19/2002 | US20020132018 Use of non-alkalized cocoa solids in a drink |
| 09/19/2002 | DE10112768A1 New heterocyclic-substituted phenyl compounds, are Factor Xa and Factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, inflammation, restenosis or tumor diseases |
| 09/19/2002 | DE10112198A1 Substituierte Dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-amine Substituted dimethyl- [1- (1-phenyl-cyclohexyl) -piperidin-3-ylmethyl] -amines |
| 09/19/2002 | DE10112151A1 New 5-(4-(indolyl-alkyl)-piperazino)-benzofuran-2-carboxamides useful e.g. for treating depression, anxiety, psychiatric or cerebral disorders or pain, are 5-HT-1A receptor agonists and 5-HT reuptake inhibitors |
| 09/19/2002 | DE10111843A1 Verbindungen zur Behandlung von inflammatorischen Erkrankungen Compounds for the treatment of inflammatory disorders |
| 09/19/2002 | DE10111842A1 Antithrombotische Carbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel Antithrombotic carboxamides, their preparation and their use as medicaments |
| 09/19/2002 | DE10110754A1 Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 09/19/2002 | DE10110438A1 Substituierte 2-Oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 09/19/2002 | DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use |
| 09/19/2002 | CA2473979A1 Method for identifying inhibitors of g protein coupled receptor signaling |
| 09/19/2002 | CA2473156A1 Rxr activating molecules |
| 09/19/2002 | CA2458479A1 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof |
| 09/19/2002 | CA2441495A1 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | CA2441210A1 Novel peptide ligands of leukocyte integrins |
| 09/19/2002 | CA2441088A1 1-butyric acid derivatives such as carbomethoxypropionyl cyanide or leflunomide derivatives, and the therapeutic use thereof |
| 09/19/2002 | CA2440974A1 High affinity integrin polypeptides and uses thereof |
| 09/19/2002 | CA2440973A1 Use of steroid derivatives for the treatment of a benighn and/or malignant tumour |
| 09/19/2002 | CA2440834A1 Anti-epileptogenic agents |
| 09/19/2002 | CA2440773A1 Novel mhc molecule constructs, and methods of employing these constructs for diagnosis and therapy, and uses of mhc molecules |
| 09/19/2002 | CA2440758A1 Substituted dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-amines |
| 09/19/2002 | CA2440757A1 Substituted tetracycline compounds as synergistic antifungal agents |
| 09/19/2002 | CA2440618A1 Immunoglobulin superfamily proteins |
| 09/19/2002 | CA2440284A1 Ph-dependent nmda receptor antagonists |